• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育性 Hippo-Notch 信号通路与前列腺癌中 DNA 损伤反应的相互作用。

Interplay of Developmental Hippo-Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer.

机构信息

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.

Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.

出版信息

Cells. 2022 Aug 7;11(15):2449. doi: 10.3390/cells11152449.

DOI:10.3390/cells11152449
PMID:35954292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9367915/
Abstract

Prostate cancer belongs in the class of hormone-dependent cancers, representing a major cause of cancer incidence in men worldwide. Since upon disease onset almost all prostate cancers are androgen-dependent and require active androgen receptor (AR) signaling for their survival, the primary treatment approach has for decades relied on inhibition of the AR pathway via androgen deprivation therapy (ADT). However, following this line of treatment, cancer cell pools often become resistant to therapy, contributing to disease progression towards the significantly more aggressive castration-resistant prostate cancer (CRPC) form, characterized by poor prognosis. It is, therefore, of critical importance to elucidate the molecular mechanisms and signaling pathways underlying the progression of early-stage prostate cancer towards CRPC. In this review, we aim to shed light on the role of major signaling pathways including the DNA damage response (DDR) and the developmental Hippo and Notch pathways in prostate tumorigenesis. We recapitulate key evidence demonstrating the crosstalk of those pathways as well as with pivotal prostate cancer-related 'hubs' such as AR signaling, and evaluate the clinical impact of those interactions. Moreover, we attempt to identify molecules of the complex DDR-Hippo-Notch interplay comprising potentially novel therapeutic targets in the battle against prostate tumorigenesis.

摘要

前列腺癌属于激素依赖性癌症,是全球男性癌症发病率的主要原因。由于疾病发生时几乎所有的前列腺癌都依赖雄激素,并且需要活跃的雄激素受体 (AR) 信号来维持其生存,因此主要的治疗方法几十年来一直依赖于通过雄激素剥夺疗法 (ADT) 抑制 AR 通路。然而,采用这种治疗方法后,癌细胞池往往会对治疗产生耐药性,导致疾病向侵袭性更强的去势抵抗性前列腺癌 (CRPC) 发展,预后较差。因此,阐明早期前列腺癌向 CRPC 发展的分子机制和信号通路至关重要。在这篇综述中,我们旨在阐明包括 DNA 损伤反应 (DDR) 和发育中的 Hippo 和 Notch 通路在内的主要信号通路在前列腺肿瘤发生中的作用。我们总结了关键证据,证明了这些通路之间以及与 AR 信号等关键的前列腺癌相关“枢纽”之间的相互作用,并评估了这些相互作用的临床影响。此外,我们试图确定复杂的 DDR-Hippo Notch 相互作用中的分子,这些分子可能是对抗前列腺肿瘤发生的潜在新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd39/9367915/cabd5439057f/cells-11-02449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd39/9367915/182d50677cd2/cells-11-02449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd39/9367915/cabd5439057f/cells-11-02449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd39/9367915/182d50677cd2/cells-11-02449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd39/9367915/cabd5439057f/cells-11-02449-g002.jpg

相似文献

1
Interplay of Developmental Hippo-Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer.发育性 Hippo-Notch 信号通路与前列腺癌中 DNA 损伤反应的相互作用。
Cells. 2022 Aug 7;11(15):2449. doi: 10.3390/cells11152449.
2
Androgen receptors in hormone-dependent and castration-resistant prostate cancer.雄激素受体在激素依赖性和去势抵抗性前列腺癌中的作用。
Pharmacol Ther. 2013 Dec;140(3):223-38. doi: 10.1016/j.pharmthera.2013.07.003. Epub 2013 Jul 13.
3
Targeting the androgen receptor signaling pathway in advanced prostate cancer.针对晚期前列腺癌的雄激素受体信号通路。
Am J Health Syst Pharm. 2022 Jul 22;79(15):1224-1235. doi: 10.1093/ajhp/zxac105.
4
MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials.去势抵抗性前列腺癌中微小RNA对雄激素受体的调控:前提、前景与潜力
Curr Mol Pharmacol. 2021 Oct 25;14(4):559-569. doi: 10.2174/1874467213666201223121850.
5
Platelet-Synthesized Testosterone in Men with Prostate Cancer Induces Androgen Receptor Signaling.前列腺癌男性中血小板合成的睾酮诱导雄激素受体信号传导。
Neoplasia. 2015 Jun;17(6):490-6. doi: 10.1016/j.neo.2015.05.003.
6
Interplay between orphan nuclear receptors and androgen receptor-dependent or-independent growth signalings in prostate cancer.孤儿核受体与雄激素受体依赖性和非依赖性生长信号在前列腺癌中的相互作用。
Mol Aspects Med. 2021 Apr;78:100921. doi: 10.1016/j.mam.2020.100921. Epub 2020 Oct 26.
7
Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.在分子水平上理解前列腺癌雄激素剥夺抗性的机制。
Eur Urol. 2015 Mar;67(3):470-9. doi: 10.1016/j.eururo.2014.09.049. Epub 2014 Oct 8.
8
Androgen receptor: what we know and what we expect in castration-resistant prostate cancer.雄激素受体:我们对去势抵抗性前列腺癌的了解与期望
Int Urol Nephrol. 2018 Oct;50(10):1753-1764. doi: 10.1007/s11255-018-1964-0. Epub 2018 Aug 20.
9
RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.RGS2对去势抵抗性前列腺癌中去势抵抗的发展及癌症特异性生存具有预后价值。
Prostate. 2020 Aug;80(11):799-810. doi: 10.1002/pros.23994. Epub 2020 May 25.
10
Restoration of the cellular secretory milieu overrides androgen dependence of in vivo generated castration resistant prostate cancer cells overexpressing the androgen receptor.恢复细胞分泌微环境可克服体内产生的过表达雄激素受体的去势抵抗性前列腺癌细胞对雄激素的依赖性。
Biochem Biophys Res Commun. 2016 Jul 22;476(2):69-74. doi: 10.1016/j.bbrc.2016.05.058. Epub 2016 May 12.

引用本文的文献

1
The emerging role of intestinal stem cells in ulcerative colitis.肠道干细胞在溃疡性结肠炎中的新作用。
Front Med (Lausanne). 2025 Mar 25;12:1569328. doi: 10.3389/fmed.2025.1569328. eCollection 2025.
2
Androgen Signaling in Prostate Cancer: When a Friend Turns Foe.前列腺癌中的雄激素信号传导:当朋友变成敌人时。
Endocr Metab Immune Disord Drug Targets. 2025;25(1):37-56. doi: 10.2174/0118715303313528240523101940.
3
Epigenetic-related gene-based prognostic model construction and validation in prostate adenocarcinoma.基于表观遗传相关基因的前列腺腺癌预后模型构建与验证

本文引用的文献

1
53BP1-mediated recruitment of RASSF1A to ribosomal DNA breaks promotes local ATM signaling.53BP1 介导的 RASSF1A 招募到核糖体 DNA 断裂处促进局部 ATM 信号转导。
EMBO Rep. 2022 Aug 3;23(8):e54483. doi: 10.15252/embr.202154483. Epub 2022 Jun 27.
2
The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance?细胞外基质硬化:前列腺癌进展和去势抵抗的触发因素?
Cancers (Basel). 2022 Jun 11;14(12):2887. doi: 10.3390/cancers14122887.
3
Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance.
Heliyon. 2024 May 9;10(10):e30941. doi: 10.1016/j.heliyon.2024.e30941. eCollection 2024 May 30.
4
Unveiling the mechanisms and challenges of cancer drug resistance.揭示癌症药物耐药性的机制和挑战。
Cell Commun Signal. 2024 Feb 12;22(1):109. doi: 10.1186/s12964-023-01302-1.
5
Oxidative balance score and risk of cancer: a systematic review and meta-analysis of observational studies.氧化平衡评分与癌症风险:观察性研究的系统评价和荟萃分析。
BMC Cancer. 2023 Nov 24;23(1):1143. doi: 10.1186/s12885-023-11657-w.
6
Prostate Cancer Stem Cells: Biology and Treatment Implications.前列腺癌干细胞:生物学和治疗意义。
Int J Mol Sci. 2023 Oct 4;24(19):14890. doi: 10.3390/ijms241914890.
7
A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer.GATA2-CDC6 轴调节雄激素受体阻断诱导的前列腺癌衰老。
J Exp Clin Cancer Res. 2023 Jul 29;42(1):187. doi: 10.1186/s13046-023-02769-z.
8
Cucurbitacin-B instigates intrinsic apoptosis and modulates Notch signaling in androgen-dependent prostate cancer LNCaP cells.葫芦素B可引发雄激素依赖性前列腺癌LNCaP细胞的内源性凋亡并调节Notch信号通路。
Front Pharmacol. 2023 Jun 28;14:1206981. doi: 10.3389/fphar.2023.1206981. eCollection 2023.
9
The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment.河马通路效应因子YAP/TAZ-TEAD癌蛋白作为肿瘤微环境中新兴的治疗靶点。
Cancers (Basel). 2023 Jul 2;15(13):3468. doi: 10.3390/cancers15133468.
10
Multitasking Proteins and Their Involvement in Pathogenesis.多功能蛋白及其在发病机制中的作用。
Cells. 2023 May 24;12(11):1460. doi: 10.3390/cells12111460.
类蓬乱蛋白激酶1:一种在转移性去势抵抗性前列腺癌进展和治疗抵抗发展中具有多方面作用的新因子。
Cancer Drug Resist. 2022 Jan 19;5(1):93-101. doi: 10.20517/cdr.2021.109. eCollection 2022.
4
CRISPR-Cas9-mediated induction of large chromosomal inversions in human bronchial epithelial cells.CRISPR-Cas9 介导的人支气管上皮细胞中大型染色体倒位的诱导。
STAR Protoc. 2022 Mar 18;3(2):101257. doi: 10.1016/j.xpro.2022.101257. eCollection 2022 Jun 17.
5
Exploiting senescence for the treatment of cancer.利用衰老治疗癌症。
Nat Rev Cancer. 2022 Jun;22(6):340-355. doi: 10.1038/s41568-022-00450-9. Epub 2022 Mar 3.
6
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.Hippo 通路与癌症:YAP/TAZ 和 TEAD 作为癌症治疗靶点。
Clin Sci (Lond). 2022 Feb 11;136(3):197-222. doi: 10.1042/CS20201474.
7
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
8
Targeting PI3K/Akt signal transduction for cancer therapy.针对 PI3K/Akt 信号转导通路的癌症治疗策略。
Signal Transduct Target Ther. 2021 Dec 16;6(1):425. doi: 10.1038/s41392-021-00828-5.
9
RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1.RASSF1A 通过 SNURF/RNF4 介导的 HES1 泛素化破坏 NOTCH 信号通路。
EMBO Rep. 2022 Feb 3;23(2):e51287. doi: 10.15252/embr.202051287. Epub 2021 Dec 13.
10
BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations.BRCA 基因突变与前列腺癌:评估、影响及治疗策略考量。
Int J Mol Sci. 2021 Nov 23;22(23):12628. doi: 10.3390/ijms222312628.